Sodium vs Potassium Education to Improve Vascular Health

April 20, 2026 updated by: Andrea Lobene, Florida State University

Improving Vascular Health Using Nutrition Education Aimed At Increasing Potassium Intake Versus Reducing Sodium Intake

The goal of this clinical trial is to determine if a self-selected high potassium diet is easier to achieve and more effective at improving vascular health than a low sodium diet in generally healthy young adults who typically consume more than the recommended amount of sodium. The main questions it aims to answer are:

  1. Is it easier for young adults to increase their potassium intake, rather than reduce their sodium intake?
  2. Is a self-selected high potassium diet better at improving vascular health compared to a self-selected low sodium diet?

Researchers will compare the effectiveness of an education-based intervention centered only on increasing dietary potassium intake against an education-based intervention centered only on reducing dietary sodium intake.

Participants will be randomly assigned to receive comprehensive dietary education on adopting either a high-potassium diet or a low-sodium diet.

Education will be delivered in four weekly one-on-one sessions. Following the four-week education period, participants will be encouraged to change their diet based on what they have learned. Measures of dietary compliance (urine samples and diet records) and cardiovascular health (blood pressure, endothelial function) will be assessed at two, four, and six months post-education.

Study Overview

Detailed Description

High sodium diets are a major contributor to cardiovascular disease. Unfortunately, reducing sodium intake can be challenging. It is known that increasing potassium intake can improve cardiovascular disease risk factors in a laboratory setting. The investigators are hoping to show that it is more feasible and effective for individuals to increase their potassium intake, rather than reduce their sodium intake, to improve cardiovascular disease risk factors, including blood pressure and endothelial function.

In this study, participants will be randomly assigned to receive individualized education over the course of four weeks to help them adopt one of two dietary patterns: 1) a self-selected low sodium diet (goal: ≤1,500 mg/day) or 2) a self-selected high potassium diet (goal: ≥4,700 mg/day). Participants will be provided individualized nutrition education once per week, at the participant's convenience by trained study staff to help them meet the target nutrition goals. No food, supplements, or devices will be provided to participants, and participants will be advised not to take any dietary supplements containing potassium during the intervention and follow-up period. Follow up with participants will be every two months for six months post-education to measure compliance with the desired dietary changes as well as changes in cardiovascular health.

Study Type

Interventional

Enrollment (Estimated)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Andrea Lobene, PhD, RD, LD
  • Phone Number: 850-644-1829
  • Email: alobene@fsu.edu

Study Contact Backup

  • Name: FSU Ann's College
  • Phone Number: 850-644-6685

Study Locations

    • Florida
      • Tallahassee, Florida, United States, 32304
        • Recruiting
        • Florida State University
        • Contact:
          • Andrea Lobene, PhD, RD, LD
          • Phone Number: 850-644-1829
          • Email: alobene@fsu.edu

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Willing and able to attend in-person laboratory visits
  • Usual sodium intake ≥3,000 mg/d for females and ≥4,000 mg/d for males
  • Usual potassium intake ≤2,500 mg/d in females and ≤3,000 mg/d in males

Exclusion Criteria:

  • BMI ≥35 kg/m2
  • Seated blood pressure ≥130/80 mmHg
  • Current diagnosis or history of diabetes, renal disease, cancer, cardiovascular disease, or major cardiovascular event (e.g. heart attack or stroke)
  • Current or recent use of a diuretic (within the past 6 months)
  • Elevated blood lipids (LDL cholesterol ≥190 mg/dL)
  • Elevated serum potassium level (>5.1 mmol/L)
  • Elevated BUN (>22 mg/dL)
  • Elevated creatinine (>1.2 mg/dL)
  • Low eGFR (<90 mL/min/1.73 m²)
  • Current or recent use of tobacco, nicotine, or illicit drugs
  • Radical hysterectomy or oophorectomy (females)*
  • Pregnant or lactating
  • Following a weight-loss diet, or intending to gain or lose weight during the study period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High potassium dietary education
Participants assigned to this intervention arm will receive four weekly individualized education sessions on how to increase their dietary potassium intake.
Active Comparator: Low sodium dietary education
Participants assigned to this intervention arm will receive four weekly individualized education sessions on how to reduce their dietary sodium intake.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in dietary sodium intake
Time Frame: Baseline; 2 month, 4month, 6month
Dietary sodium intake will be assessed via participant self-reported 3 day diet record
Baseline; 2 month, 4month, 6month
Change in dietary potassium intake
Time Frame: Baseline, 2month, 4month, 6month
Dietary potassium intake will be assessed via participant self-reported 3-day diet record
Baseline, 2month, 4month, 6month
Change in 24-hour urinary sodium excretion
Time Frame: Baseline, 2month, 4month, 6month
Urinary sodium excretion obtained from 24-hour urine sample
Baseline, 2month, 4month, 6month
Change in 24-hour urinary potassium excretion
Time Frame: Baseline, 2month, 4month, 6month
Urinary potassium excretion measured from 24-hour urine sample
Baseline, 2month, 4month, 6month
Change in Blood pressure
Time Frame: Baseline; 2 month, 4month, 6month
Seated, automated blood pressure mmHg
Baseline; 2 month, 4month, 6month
Change in Endothelial function
Time Frame: Baseline; 2 month, 4month, 6month
brachial artery flow-mediated dilation as measured in % dilation
Baseline; 2 month, 4month, 6month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Direct measurement of arterial stiffness
Time Frame: Baseline, 2month, 4month, 6month
Carotid-femoral pulse wave velocity reported in m/s
Baseline, 2month, 4month, 6month
Indirect measurement of arterial stiffness
Time Frame: Baseline, 2month, 4month, 6month
Augmentation obtained from the brachial artery pressure waveform using a blood pressure cuff on the upper arm, reported as %
Baseline, 2month, 4month, 6month

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Body weight
Time Frame: Baseline; 2 month, 4month, 6month
body weight assessed in kilograms
Baseline; 2 month, 4month, 6month
Change in total cholesterol
Time Frame: Baseline, 2month, 4month, 6month
Fasting total cholesterol obtained as part of standard lipid panel
Baseline, 2month, 4month, 6month
Change in LDL cholesterol
Time Frame: Baseline, 2month, 4month, 6month
Fasting LDL cholesterol obtained as part of a standard lipid panel
Baseline, 2month, 4month, 6month
Change in HDL cholesterol
Time Frame: Baseline, 2month, 4month, 6month
Fasting HDL cholesterol obtained as part of a standard lipid panel
Baseline, 2month, 4month, 6month
Change in triglycerides
Time Frame: Baseline, 2month, 4month, 6month
Fasting triglycerides obtained as part of a standard lipid panel
Baseline, 2month, 4month, 6month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Andrea Lobene, PhD, RD, LD, Florida State University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 20, 2026

Primary Completion (Estimated)

September 30, 2027

Study Completion (Estimated)

September 30, 2027

Study Registration Dates

First Submitted

October 24, 2025

First Submitted That Met QC Criteria

October 24, 2025

First Posted (Actual)

October 28, 2025

Study Record Updates

Last Update Posted (Actual)

April 23, 2026

Last Update Submitted That Met QC Criteria

April 20, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • STUDY00005997
  • 2025-67017-44996 (Other Grant/Funding Number: United States Department of Agriculture)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on High potassium dietary education/counseling

Subscribe